Literature DB >> 32980875

The impact of low-dose anticoagulation therapy on peripheral artery disease: insights from the VOYAGER trial.

Eri Fukaya1, Nicholas J Leeper1.   

Abstract

Entities:  

Keywords:  Atherothrombosis; Low-dose anticoagulation; Peripheral artery disease (PAD); VOYAGER trial

Year:  2020        PMID： 32980875      PMCID： PMC7519885          DOI： 10.1093/cvr/cvaa225

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  9 in total

Review 1.  The genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions.

Authors:  Iftikhar J Kullo; Nicholas J Leeper
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

2.  The evolving treatment of peripheral arterial disease: preventing ischaemic events in the post-COMPASS era.

Authors:  Eric Kaplovitch; Sonia S Anand
Journal:  Cardiovasc Res       Date:  2019-10-01       Impact factor: 10.787

3.  Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.

Authors:  Sonia S Anand; Jackie Bosch; John W Eikelboom; Stuart J Connolly; Rafael Diaz; Peter Widimsky; Victor Aboyans; Marco Alings; Ajay K Kakkar; Katalin Keltai; Aldo P Maggioni; Basil S Lewis; Stefan Störk; Jun Zhu; Patricio Lopez-Jaramillo; Martin O'Donnell; Patrick J Commerford; Dragos Vinereanu; Nana Pogosova; Lars Ryden; Keith A A Fox; Deepak L Bhatt; Frank Misselwitz; John D Varigos; Thomas Vanassche; Alvaro A Avezum; Edmond Chen; Kelley Branch; Darryl P Leong; Shrikant I Bangdiwala; Robert G Hart; Salim Yusuf
Journal:  Lancet       Date:  2017-11-10       Impact factor: 79.321

4.  The use of machine learning for the identification of peripheral artery disease and future mortality risk.

Authors:  Elsie Gyang Ross; Nigam H Shah; Ronald L Dalman; Kevin T Nead; John P Cooke; Nicholas J Leeper
Journal:  J Vasc Surg       Date:  2016-06-03       Impact factor: 4.268

5.  Rivaroxaban in Peripheral Artery Disease after Revascularization.

Authors:  Marc P Bonaca; Rupert M Bauersachs; Sonia S Anand; E Sebastian Debus; Mark R Nehler; Manesh R Patel; Fabrizio Fanelli; Warren H Capell; Lihong Diao; Nicole Jaeger; Connie N Hess; Akos F Pap; John M Kittelson; Ivan Gudz; Lajos Mátyás; Dainis K Krievins; Rafael Diaz; Marianne Brodmann; Eva Muehlhofer; Lloyd P Haskell; Scott D Berkowitz; William R Hiatt
Journal:  N Engl J Med       Date:  2020-03-28       Impact factor: 91.245

6.  Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia.

Authors:  Navneet Narula; Andrew J Dannenberg; Jeffrey W Olin; Deepak L Bhatt; Kipp W Johnson; Girish Nadkarni; James Min; Sho Torii; Priti Poojary; Sonia S Anand; Jeroen J Bax; Salim Yusuf; Renu Virmani; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2018-08-27       Impact factor: 24.094

Review 7.  Rivaroxaban and Aspirin in Peripheral Vascular Disease: a Review of Implementation Strategies and Management of Common Clinical Scenarios.

Authors:  Graham R McClure; Eric Kaplovitch; Sukrit Narula; Vinai C Bhagirath; Sonia S Anand
Journal:  Curr Cardiol Rep       Date:  2019-08-30       Impact factor: 2.931

8.  Genome-wide association study of peripheral artery disease in the Million Veteran Program.

Authors:  Derek Klarin; Julie Lynch; Krishna Aragam; Mark Chaffin; Themistocles L Assimes; Jie Huang; Kyung Min Lee; Qing Shao; Jennifer E Huffman; Pradeep Natarajan; Shipra Arya; Aeron Small; Yan V Sun; Marijana Vujkovic; Matthew S Freiberg; Lu Wang; Jinbo Chen; Danish Saleheen; Jennifer S Lee; Donald R Miller; Peter Reaven; Patrick R Alba; Olga V Patterson; Scott L DuVall; William E Boden; Joshua A Beckman; J Michael Gaziano; John Concato; Daniel J Rader; Kelly Cho; Kyong-Mi Chang; Peter W F Wilson; Christopher J O'Donnell; Sekar Kathiresan; Philip S Tsao; Scott M Damrauer
Journal:  Nat Med       Date:  2019-07-08       Impact factor: 53.440

9.  Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease.

Authors:  Martin R Cowie; André Lamy; Pierre Levy; Stuart Mealing; Aurélie Millier; Paul Mernagh; Olivier Cristeau; Kevin Bowrin; Jean-Baptiste Briere
Journal:  Cardiovasc Res       Date:  2020-09-01       Impact factor: 10.787
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.